<DOC>
	<DOCNO>NCT00004583</DOCNO>
	<brief_summary>The purpose study see safe new protease inhibitor ( PI ) well fight HIV infection . A PI drug stop HIV use healthy cell make virus . This study compare new PI combination ABT-378 plus ritonavir ( RTV ) another PI , nelfinavir ( NFV ) . Earlier study suggest ABT-378/RTV good perhaps well NFV fight HIV infection .</brief_summary>
	<brief_title>A Phase III Study Comparing Two Different Anti-HIV Drug Combinations HIV-Positive Patients Without Previous Anti-HIV Drug Therapy</brief_title>
	<detailed_description>Based accumulated study date , expect ABT-378/ritonavir provide efficacy least good ( superior ) nelfinavir use combination reverse transcriptase inhibitor . Patients equally randomize one two treatment arm . In one arm , approximately 330 patient receive ABT-378/ritonavir plus nelfinavir placebo . In arm , approximately 330 patient receive nelfinavir plus ABT-378/ritonavir placebo . In arm , protease inhibitor blind investigator , patient , sponsor . Both arm receive open-label stavudine lamivudine . Vital sign measurement , physical examination , ECGs , routine clinical laboratory evaluation , determination antiviral immunologic activity perform interval throughout study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion Criteria You may eligible trial : Are HIV positive . Have viral load ( level HIV blood ) 400 copies/ml . Are age 12 older . Agree practice abstinence use effective method birth control study . Exclusion Criteria You eligible trial : Have take antiHIV drug 14 day past , ever take d4T 3TC . Are seriously ill AIDSrelated infection . Are pregnant breastfeeding . Are take certain medication .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Stavudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>ABT 378</keyword>
</DOC>